Efficacy and safety of linezolid in liver transplant patients.
about
Multidrug-resistant organisms in liver transplant: Mitigating risk and managing infections.Emergence of linezolid resistance in hepatobiliary infections caused by Enterococcus faecium.Methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus infections in solid organ transplantation.Dosing strategies to optimize currently available anti-MRSA treatment options (Part 2: PO options).Management of bacterial and fungal infections in end stage liver disease and liver transplantation: Current options and future directions
P2860
Efficacy and safety of linezolid in liver transplant patients.
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Efficacy and safety of linezolid in liver transplant patients.
@ast
Efficacy and safety of linezolid in liver transplant patients.
@en
type
label
Efficacy and safety of linezolid in liver transplant patients.
@ast
Efficacy and safety of linezolid in liver transplant patients.
@en
prefLabel
Efficacy and safety of linezolid in liver transplant patients.
@ast
Efficacy and safety of linezolid in liver transplant patients.
@en
P2093
P2860
P1476
Efficacy and safety of linezolid in liver transplant patients.
@en
P2093
B Juntermanns
G M Kaiser
J Treckmann
P2860
P304
P356
10.1111/J.1399-3062.2011.00617.X
P577
2011-02-28T00:00:00Z